Activity Pulse — CEO/CFO & Board Transitions
Counts of role transitions across all tracked public companies. YoY compares the trailing 12 months against the 12 months before that.
| Role | This Week | MTD | Last 12 Mo. | Prior 12 Mo. | YoY |
|---|---|---|---|---|---|
| CEO transitions | 2 | 36 | 484 | 461 | +5.0% |
| CFO transitions | 10 | 46 | 704 | 733 | -4.0% |
| Director adds | 31 | 192 | 2,717 | 2,729 | -0.4% |
| Director exits | 57 | 343 | 2,904 | 2,859 | +1.6% |
Consumer Brands Swap Leaders As Shares Lag
Consumer Brands With Tired Narratives
Planet Fitness (PLNT) tapped Sudhanshu Priyadarshi as CFO and president, international, ending Tom Fitzgerald’s interim stint. The hire gives PLNT 3 CFOs in 3y, while the stock has collapsed 59% from its July 2025 peak and carries HIGH activist risk.
PLANET FITNESS INC (PLNT)Consumer Cyclical
$4.0B · 1Y TSR -50.8% · board C · activist HIGH
5Y max drawdown: 59.3% (peak 2025-07-21 → trough 2026-05-04)
Sudhanshu Priyadarshi has been appointed as Chief Financial Officer and President, International, effective June 25, 2026, transitioning from the role of Interim Chief Financial Officer held by Tom Fitzgerald, who will remain in an advisory role through mid-September.
Domino’s Pizza (DPZ) moved Russell Weiner to executive chair and handed the CEO seat to Joseph Jordan. That is succession, but not much comfort: shares are down 36% in the past year while the S&P gained 21, and the company screens as HIGH activist risk.
Molson Coors (TAP) named Simon Kerry interim managing director for EMEA&APAC while Philip Whitehead temporarily steps away for medical reasons. The handoff lands at a brewer running roughly 31 points behind the S&P over both one and three years.
Biotech Winners Still Rebuild
Revolution Medicines (RVMD) is the rare governance story attached to a rocket ship: Steve Kelsey will retire from R&D, move to senior adviser and then join the board. The stock collapsed 54% from its Nov. 2021 peak before ripping to a five-year high, up 444% over five years.
REVOLUTION MEDICINES INC (RVMD)Healthcare
$33.3B · 1Y TSR +363.9% · board B+ · activist LOW
5Y max drawdown: 53.5% (peak 2021-11-01 → trough 2022-05-09)
On June 18, 2026, Steve Kelsey, M.D., FRCP, FRCPath, announced his retirement effective January 4, 2027, transitioning to a senior advisor role on July 1, 2026, with a prospective appointment to the Board upon retirement.
Centessa Pharmaceuticals (CNTA) is rotating the room after an even wilder ride: CEO Mario Accardi and several executives are exiting, with two directors coming in. The stock collapsed 87% from its Aug. 2021 peak before surging 453% in one year, yet the board still shows 11 director exits in 5 years.
CENTESSA PHARMACEUTICALS PLC (CNTA)Healthcare
$6.2B · 1Y TSR +452.8% · board B+ · activist LOW
5Y max drawdown: 86.6% (peak 2021-08-30 → trough 2022-12-26)
Several executives have exited their roles at Centessa Pharmaceutical and two new directors have been appointed.
Big-Cap Succession Splits
NIKE (NKE) tapped David Denton as CFO while Matthew Friend shifts to an advisory role before separating; Friend also sits on United Airlines’ board. This is a finance reset at a D-rated board, with shares down 31% in a year while the S&P gained 21.
JPMorgan Chase (JPM) elected Doug Petno and Troy Rohrbaugh co-presidents as Marianne Lake retires, a cleaner succession signal than most of the week produced. The $887 billion bank has run 18 points ahead of the S&P over three years, so this looks like bench management, not repair work.
Role Moves That Matter
CEO Transitions
- Rayonier Advanced Materials (RYAM) named Daniel Krawczyk CEO, extending a 3-CEO-in-3-years reset at a $604 million chemicals maker.
- CVR Energy (CVI) replaced Mark Pytosh with Dane Neumann and added an interim CFO, after 8 director exits in five years.
CFO Transitions
- SolarEdge Technologies (SEDG) saw Asaf Alperovitz step down as CFO, with the stock still down 28% over five years.
- TPG (TPG) appointed Axel André CFO as Jack Weingart shifted roles, with shares roughly 40 points behind the S&P over one year.
- Best Buy (BBY) will lose CFO Matt Bilunas after 6.9 years, while the company screens as HIGH activist risk.
Board / Director Changes
- NeoGenomics (NEO) added Carolyn Starrett to a C- board that has recorded 9 director exits in five years.
- TD SYNNEX (SNX) added Douglas Britt, who also serves on Helios Technologies and Benchmark Electronics boards, after 11 director exits in five years.
- Illumina (ILMN) expanded its board to 10 with Daniel Skovronsky, continuing a five-year stretch with 7 director exits.
Sector Turnover Rates — Where the Churn Concentrates
Share of each sector’s public companies that saw a CEO or CFO transition in the window. Cells colored on each column’s actual min-max spread — darker = more activity, not better or worse. (Industry-typical CEO turnover runs ~10–15% annually; a low rate may indicate stability or stagnation.)
| Sector | # Co. | CEO · 30D | CEO · 1Y | CFO · 30D | CFO · 1Y |
|---|---|---|---|---|---|
| Consumer Defensive | 154 | 4.5% | 24.7% | 3.2% | 24.7% |
| Energy | 129 | 2.3% | 20.2% | 1.6% | 24.0% |
| Basic Materials | 171 | 2.9% | 17.5% | 4.1% | 22.2% |
| Consumer Cyclical | 359 | 2.8% | 15.6% | 3.9% | 24.5% |
| Technology | 485 | 1.6% | 15.1% | 3.3% | 21.9% |
| Healthcare | 787 | 2.7% | 15.0% | 2.9% | 21.1% |
| Industrials | 416 | 2.4% | 14.7% | 2.9% | 20.9% |
| Communication Services | 129 | 0.8% | 13.2% | 2.3% | 17.1% |
| Financial Services | 552 | 3.1% | 12.5% | 2.4% | 13.9% |
| Utilities | 72 | 0.0% | 9.7% | 2.8% | 13.9% |
Beyond the headline
Finance Benches Look Thin
Accounting and finance seats kept wobbling at companies with longer credibility repairs ahead (SolarEdge, Best Buy, Expand Energy), where guidance resets usually start in the CFO chair.
Healthcare— 30 companies
|
$33.3B · +363.9% 1Y · Board B+ · LOW activist risk
On June 18, 2026, Steve Kelsey, M.D., FRCP, FRCPath, announced his retirement effective January 4, 2027, transitioning to a senior advisor role on July 1, 2026, with a prospective appointment to the Board upon retirement.(view source)
|
|
$6.2B · +452.8% 1Y · Board B+ · LOW activist risk
Several executives have exited their roles at Centessa Pharmaceutical and two new directors have been appointed.(view source)
|
|
$1.4B · +91.2% 1Y · Board C- · HIGH activist risk
On June 23, 2026, Carolyn S. Starrett was appointed as a director of NeoGenomics, Inc.(view source)
|
|
$766.6M · +107.5% 1Y · Board B- · HIGH activist risk
On June 25, 2026, Mark Eisner, M.D., M.P.H. was appointed as a Class I director of Jade Biosciences, Inc. and also joined the Nominating and Corporate Governance Committee.(view source)
|
|
$24.9B · +90.6% 1Y · Board C- · LOW activist risk
The Board of Illumina, Inc. appointed Daniel M. Skovronsky, M.D., Ph.D., as a new director, expanding the Board size to ten members, effective June 16, 2026.(view source)
|
|
$30.3B · +21.0% 1Y · Board C · HIGH activist risk
Centene Corporation elected Lauren Tyler to the Board of Directors effective June 19, 2026, to fill a vacancy, with a term expiring at the 2027 annual meeting.(view source)
|
|
$2.7B · +91.4% 1Y · Board B · LOW activist risk
Kendall Forbes will retire, David Morris will transition to COO, and Will Mudd will be promoted to CFO effective July 1, 2026.(view source)
|
|
$3.0B · +97.8% 1Y · Board C- · HIGH activist risk
On June 22, 2026, Barry E. Greene was elected as a Class I director of Dyne Therapeutics, Inc. to serve on the Board until the Company’s 2027 Annual Meeting of Stockholders.(view source)
|
|
$10.2B · -49.8% 1Y · Board C- · HIGH activist risk
On June 24, 2026, Jonathan J. Mazelsky was appointed as a Class II director of Insulet Corporation, effective July 1, 2026.(view source)
|
|
$962.9M · -51.9% 1Y · Board D · HIGH activist risk
Micah Young has been appointed as Chief Financial Officer of QuidelOrtho Corporation, succeeding Joseph M. Busky, who is transitioning into retirement.(view source)
|
|
$3.3B · +123.0% 1Y · Board B+ · LOW activist risk
On June 22, 2026, Denise W. Warren stepped down as Non-Executive Chairman of the Board and Mark Fioravanti was appointed as Non-Executive Chairman of the Board, effective immediately after the Annual Meeting. Additionally, Dr. Jordan R. Asher’s term as a member of the Board expired at the Annual Meeting where several directors were elected for a one-year term.(view source)
|
|
$753.3M · +275.8% 1Y · Board B · ELEVATED activist risk
Ron Philip has been appointed as a director of Avalo Therapeutics, effective June 23, 2026.(view source)
|
|
$31.7M · +134.6% 1Y · Board D · ELEVATED activist risk
Effective July 1, 2026, Zachary D. Hornby will exit his roles as President, CEO, and member of the board at Boundless Bio, while Jessica Oien will enter the role of President and principal executive officer, retaining her position as Chief Legal Officer and Corporate Secretary. Additionally, Christian Hassig, Ph.D., and Robert Doebele, M.D., Ph.D., will also exit their roles as Chief Scientific Officer and Chief Medical Officer, respectively.(view source)
|
|
$13.1B · +57.0% 1Y · Board B- · LOW activist risk
Dr. Randal W. Scott has resigned from the Board of Directors effective June 22, 2026 as his term concludes.(view source)
|
|
$528.2M · +34.2% 1Y · Board C · HIGH activist risk
On June 18, 2026, Valerie Barnett and Cytek Biosciences, Inc. agreed to terminate her position as Chief Legal Officer and Corporate Secretary effective June 29, 2026.(view source)
|
|
$12.9B · -6.1% 1Y · Board C · HIGH activist risk
C. Raymond Larkin, Jr. is retiring as Chairman of the Board effective July 1, 2026, and Kevin Conroy is appointed as the new Chairman of the Board effective the same date.(view source)
|
|
$7.1B · +62.2% 1Y · Board C+ · ELEVATED activist risk
On June 17, 2026, Jacks Lee retired from the Board of Vaxcyte, and Moncef Slaoui was appointed as a Class II director.(view source)
|
|
$2.7B · +64.9% 1Y · Board B · ELEVATED activist risk
On June 16, 2026, Yujiro S. Hata was elected as Chairman of the Board, and Terry Rosen, Ph.D., was elected as Lead Independent Director of the Board.(view source)
|
|
$478.7M · +2.9% 1Y · Board D · HIGH activist risk
Dr. Noah Berkowitz will be exiting his role as Chief Medical Officer with Arvinas, Inc. effective July 3, 2026.(view source)
|
|
$401.4M · +6.1% 1Y · Board D · HIGH activist risk
On June 17, 2026, Daniel M. Skovronsky, M.D., Ph.D., resigned from the Board of Directors of Myriad Genetics, Inc. effective immediately.(view source)
|
|
$13.2M · -66.9% 1Y · Board D · HIGH activist risk
Alex Hastie, Ph.D. has been appointed as the Chief Scientific Officer of Bionano Genomics, Inc., effective July 20, 2026.(view source)
|
|
$2.7M · -99.0% 1Y · Board D · HIGH activist risk
On June 23, 2026, INVO Fertility, Inc. acquired HRCFG, LLC from Sellers including Karen Hammond, Lisa Ray, and Nicholas Cataldo, who will provide transition services during the transition period.(view source)
|
|
$129.8M · +13.4% 1Y · Board D · LOW activist risk
Dr. Ido Schoenberg was elected as a Class III director of American Well Corporation, while Dr. Roy Schoenberg did not stand for re-election.(view source)
|
|
$40.2M · -54.9% 1Y · Board C- · ELEVATED activist risk
On June 18, 2026, Robert P. Eno will depart as CEO and Board member of Heartbeam, Inc. while Mark Strome resigned from the Board effective immediately on the same date.(view source)
|
|
$4.2M · -94.9% 1Y · Board D · HIGH activist risk
Pete O’Heeron was elected as a Class III director at the Annual Meeting, and Stacy Coen exited her role as a Class III director.(view source)
|
|
$83.5M · -62.9% 1Y · Board B- · LOW activist risk
Cory Anderson is transitioning to Executive Vice President, General Manager of Greenbrook from Senior Vice President, Chief Technology Officer, effective July 1, 2026.(view source)
|
|
$24.3M · -59.2% 1Y · Board C- · LOW activist risk
Mr. Eitan Ajchenbaum exited as Director effective June 15, 2026, while Mr. Doron Shorrer entered as a Director effective June 19, 2026.(view source)
|
|
$29.9M · -57.0% 1Y · Board C- · LOW activist risk
Shanth Thiyagalingam is exiting his role as a director effective June 30, 2025. Kelly Ulto and Greg Shilling are entering their roles as independent directors of the company.(view source)
|
|
$6.0M · -23.7% 1Y · Board D · ELEVATED activist risk
Andrea Childs will be appointed as CEO and Erik Ellingson will be appointed as CFO of Parent, while Andrew Simpson and David Wells will remain on the Board post-Closing.(view source)
|
|
$8.5M · -78.8% 1Y · Board C- · ELEVATED activist risk
Allison W. Brady resigned from the Board of Directors and related committees effective June 17, 2026.(view source)
|
Consumer Cyclical— 10 companies
|
$4.0B · -50.8% 1Y · Board C · HIGH activist risk
Sudhanshu Priyadarshi has been appointed as Chief Financial Officer and President, International, effective June 25, 2026, transitioning from the role of Interim Chief Financial Officer held by Tom Fitzgerald, who will remain in an advisory role through mid-September.(view source)
|
|
$66.7B · -30.9% 1Y · Board D · HIGH activist risk
On June 23, 2026, David Denton was appointed Executive Vice President and Chief Financial Officer (CFO) of NIKE, Inc., effective August 16, 2026, while Matthew Friend will transition to an advisory role and separate from the company on September 4, 2026.(view source)
|
|
$15.9B · +19.3% 1Y · Board C- · HIGH activist risk
Matt Bilunas, CFO of Best Buy Co., Inc., will be exiting the company effective July 31, 2026.(view source)
|
|
$10.7B · -35.8% 1Y · Board C · HIGH activist risk
Russell J. Weiner is transitioning to Executive Chairman, David A. Brandon is retiring from the Board, and Joseph H. Jordan is appointed as CEO.(view source)
|
|
$673.0M · +348.5% 1Y · Board A+ · LOW activist risk
On June 24, 2026, six individuals were elected to the Board of Directors of Envela Corporation during the annual meeting, with John G. DeLuca signing the report as the CFO.(view source)
|
|
$4.0B · +91.8% 1Y · Board C- · ELEVATED activist risk
Dustin J. Semach was appointed as a Class III director of Polaris Inc. effective June 19, 2026.(view source)
|
|
$1.3B · -34.0% 1Y · Board C- · ELEVATED activist risk
On June 19, 2026, The Wendy’s Company appointed Steven W. Cirulis as Chief Financial Officer and Chief Strategy Officer effective June 23, 2026, while Ken Cook will cease to be CFO effective on the same date and will be terminated from employment without cause as of July 31, 2026.(view source)
|
|
$6.4B · +14.7% 1Y · Board B+ · LOW activist risk
On June 22, 2026, Stacia J. Andersen and George C. Roeth were appointed as Directors to the Board of Boyd Gaming Corporation, increasing the board size from eight to ten members.(view source)
|
|
$2.3B · +11.8% 1Y · Board C · LOW activist risk
On June 19, 2026, LCI entered into amended and restated executive employment agreements with Ryan R. Smith and Jamie M. Schnur.(view source)
|
|
$19.4M · -92.9% 1Y · Board C- · HIGH activist risk
The text discusses the resignation of Julia K. Davis, the appointment of Gilbert Nathan and Michael Wartell as Independent Directors, and the resignation of CFO Jonathan Collins followed by the appointment of Marie Persichetti as the new CFO.(view source)
|
Industrials— 9 companies
|
$67.4B · +298.4% 1Y · Board A · LOW activist risk
Craig Sasser is transitioning from Regional Vice President – Atlantic Region to Chief Operating Officer, effective July 1, 2026.(view source)
|
|
$12.0B · +54.1% 1Y · Board A- · LOW activist risk
Mary Dean Hall resigned as a director, effective at the next annual meeting of shareholders.(view source)
|
|
$8.3B · -4.0% 1Y · Board C- · ELEVATED activist risk
On June 22, 2026, A. O. Smith Corporation announced the retirement of Kevin J. Wheeler as Executive Chairman effective July 1, 2026, with Stephen M. Shafer transitioning to Chairman while continuing as CEO and Director.(view source)
|
|
$8.3B · -41.8% 1Y · Board C+ · HIGH activist risk
|
|
$11.8B · +51.5% 1Y · Board A- · LOW activist risk
On June 18, 2026, John W. Swann III announced his retirement from SPX Technologies, Inc. in January 2027, transitioning from his role as President of the Detection and Measurement Segment.(view source)
|
|
$507.6M · -42.3% 1Y · Board C- · ELEVATED activist risk
Sarfraz Maredia resigned from the Board of Directors effective June 17, 2026, and Andreas Lieber was appointed as a director effective June 22, 2026.(view source)
|
|
$3.0B · -7.6% 1Y · Board C+ · ELEVATED activist risk
On June 23, 2026, W. Bradley Southern was appointed as a director of Worthington Enterprises, Inc.(view source)
|
|
$91.2M · -12.0% 1Y · Board D · HIGH activist risk
|
|
$1.7B · -30.7% 1Y · Board B- · ELEVATED activist risk
Shoshana M. Vernick has been elected as a director of Huron Consulting Group Inc. effective June 19, 2026.(view source)
|
Basic Materials— 7 companies
|
$59.0B · +97.1% 1Y · Board B+ · LOW activist risk
Daniel R. Needham is retiring and resigning from all positions at Nucor Corporation effective June 20, 2026.(view source)
|
|
$604.2M · +109.8% 1Y · Board C+ · LOW activist risk
On June 22, 2026, Daniel M. Krawczyk was appointed as Chief Executive Officer and President of Rayonier Advanced Materials Inc., and also appointed to the Board of Directors as a Class III director.(view source)
|
|
$2.5B · +75.9% 1Y · Board C · LOW activist risk
On June 22, 2026, Ryan Cotterman was appointed as the Vice President, Chief Accounting Officer of Ingevity Corporation.(view source)
|
|
$3.1B · +10.0% 1Y · Board C · LOW activist risk
Nicholas D. Giordano has been appointed as the principal accounting officer of WD-40 Company, with agreements effective on June 29, 2026.(view source)
|
|
$2.1B · +42.8% 1Y · Board B- · LOW activist risk
On June 23, 2026, Steven R. Witt retired from his role as Corporate Controller and Principal Accounting Officer, while Gwen Joseph was appointed to the same role effective the same date.(view source)
|
|
$902.0M · +14.6% 1Y · Board B- · ELEVATED activist risk
E. Forrest Jones, Jr. passed away, who was a former member of the Board of Directors and served as the General Counsel and Director Emeritus.(view source)
|
|
$412.9M · -18.0% 1Y · Board C- · HIGH activist risk
On June 17, 2026, Mary A. Tidlund announced her resignation from the board of directors, effective June 30, 2026.(view source)
|
Financial Services— 13 companies
|
$17.2B · -19.6% 1Y · Board C+ · ELEVATED activist risk
TPG Inc. appointed Axel André as CFO and Jack Weingart transitioned to CEO of the Global Wealth Solutions business.(view source)
|
|
$887.3B · +20.2% 1Y · Board B+ · LOW activist risk
On June 25, 2026, Doug Petno and Troy Rohrbaugh were elected Co-Presidents of JPMorgan Chase, with Petno becoming CEO of the Commercial & Investment Bank and Rohrbaugh becoming CEO of Consumer & Community Banking. Additionally, Marianne Lake announced her retirement.(view source)
|
|
$13.7B · +8.7% 1Y · Board B- · HIGH activist risk
On June 15, 2026, Axel André resigned as CFO effective July 17, 2026, and Laura Cockill will assume the CFO role effective June 22, 2026.(view source)
|
|
$62.5M · -78.6% 1Y · Board D · HIGH activist risk
On June 23, 2026, Gregory S. Patton was appointed as CEO and a member of the Board, while Michael Shelly was appointed as Executive Vice President and CFO of Prairie Operating Co.(view source)
|
|
$3.0B · +46.5% 1Y · Board B- · LOW activist risk
On June 18, 2026, James P. Dunigan retired from the Board of Directors of Provident Financial Services after over eight years, and on June 23, 2026, Adriano Duarte was appointed as Executive Vice President and Chief Financial Officer, effective July 1, 2026.(view source)
|
|
$26.6B · +26.4% 1Y · Board C+ · LOW activist risk
On June 19, 2026, Cincinnati Financial Corporation appointed an independent director to its board.(view source)
|
|
$7.7B · +27.1% 1Y · Board A · ELEVATED activist risk
Gregory T. Durant has resigned from Jackson Financial Inc.’s Board of Directors effective immediately due to health reasons, and Steven A. Kandarian has been appointed as Chair of the Audit Committee in his place.(view source)
|
|
$5.0B · -19.3% 1Y · Board C- · HIGH activist risk
Michael Angelina is resigning from the RLI Corp. Board of Directors effective June 30, 2026.(view source)
|
|
$1.3B · +24.9% 1Y · Board C- · HIGH activist risk
On June 22, 2026, Roy E. Halyama was appointed as President of Burke & Herbert Financial Services Corp. and Burke & Herbert Bank & Trust Company, effective July 1, 2026, succeeding H. Charles Maddy, III, who is retiring as President effective June 30, 2026.(view source)
|
|
$913.0M · +45.2% 1Y · Board C+ · HIGH activist risk
Alberto Capriles plans to retire as Senior Executive Vice President and Chief Risk Officer of Amerant Bancorp Inc. effective upon the appointment of his successor.(view source)
|
|
$1.6B · +29.0% 1Y · Board B · LOW activist risk
On June 16, 2026, Bank First Corporation elected three new directors to its Board of Directors: SriRaj Kantamneni, Tracy C. Pearson, and William J. Ring, each for a three-year term.(view source)
|
|
$49.0M · +51.7% 1Y · Board D · HIGH activist risk
|
|
$2.0M · -96.1% 1Y · Board D · HIGH activist risk
On June 18, 2026, Judah Korman was appointed Chief Operating Officer, Zack Wilder was appointed Chief Technology Officer, and Mordy Beyman was promoted to Vice President at Reliance Global Group, Inc.(view source)
|
Technology— 19 companies
|
$22.7B · +103.8% 1Y · Board B+ · ELEVATED activist risk
Douglas Britt appointed as a member of the Board of Directors for TD SYNNEX Corporation, effective June 17, 2026.(view source)
|
|
$3.5B · +171.8% 1Y · Board B- · ELEVATED activist risk
Mr. Asaf Alperovitz stepped down as CFO on May 31, 2026, and transitioned to a different role until June 9, 2026.(view source)
|
|
$1.9B · +56.1% 1Y · Board B- · LOW activist risk
Kieran O’Sullivan is transitioning to Executive Chairman on July 6, 2026, and Pratik Trivedi is entering as President and CEO on the same date.(view source)
|
|
$6.1B · +3142.3% 1Y · Board A- · LOW activist risk
On June 17, 2026, Tracy Liu was elected to the Board of Directors of AXT, Inc. as a Class II Director.(view source)
|
|
$680.2M · -40.8% 1Y · Board D · HIGH activist risk
On June 22, 2026, Eric Prengel was appointed as CFO of PagerDuty, Inc., while Howard Wilson exited the role of CFO and will serve as a Strategic Advisor.(view source)
|
|
$4.7B · -35.5% 1Y · Board D · HIGH activist risk
Robin Schulman is resigning as Chief Legal Officer; Karen Blasing and Godfrey Sullivan have been elected as Directors.(view source)
|
|
$21.9B · +31.1% 1Y · Board A- · ELEVATED activist risk
Mr. Gavin Munroe has been appointed as a director of F5, Inc. effective June 17, 2026.(view source)
|
|
$25.0B · +16.0% 1Y · Board C+ · LOW activist risk
Ryan Schneider was appointed to the Board of Directors as a Class III director effective July 1, 2026, and will also serve on the Audit Committee and Nominating and Governance Committee.(view source)
|
|
$6.2B · -33.8% 1Y · Board C- · HIGH activist risk
On June 18, 2026, Ken Exner announced his resignation as Chief Product Officer, effective July 17, 2026, to pursue another opportunity.(view source)
|
|
$1.6B · -26.7% 1Y · Board C- · HIGH activist risk
Panos Kozanian will begin a transition from his role as Executive Vice President of Product Engineering effective June 29, 2026, while continuing in the role until at least September 4, 2026.(view source)
|
|
$522.2M · +37.1% 1Y · Board B- · LOW activist risk
On June 22, 2026, NVE Corporation announced several leadership changes including the retirement of Daniel A. Baker as President and CEO, the appointment of Peter G. Eames as the new President and CEO, and board nominations for Terence W. Glarner and Carolyn W. Valentine.(view source)
|
|
$891.7M · -3.7% 1Y · Board D · ELEVATED activist risk
On June 15, 2026, Dr. Ichiro Aoki notified of his resignation from the Board and as President, while on June 18, 2026, Thomas Schiller was appointed as a Class III director.(view source)
|
|
$1.2B · +57.2% 1Y · Board C- · LOW activist risk
On June 23, 2026, Anne DelSanto was elected as a Director of ADTRAN Holdings, Inc., effective July 1, 2026, and appointed to the Compensation Committee.(view source)
|
|
$11.1B · -3.8% 1Y · Board B · ELEVATED activist risk
On June 22, 2026, Dr. David Young was appointed as Chief Operating Officer of CACI International Inc.(view source)
|
|
$7.2B · +9.9% 1Y · Board B- · ELEVATED activist risk
Effective upon the consummation of the Merger, multiple individuals resigned from the Board, while others were appointed as new directors.(view source)
|
|
$1.3B · — 1Y · Board UN · ELEVATED activist risk
David Fortunato and Andrew S. Rachleff were elected as Class I directors at Wealthfront Corporation’s Annual Meeting, serving until 2029.(view source)
|
|
$490.9M · -57.7% 1Y · Board C- · ELEVATED activist risk
Rishabh Khemka has been appointed as Chief Financial Officer of TaskUs, effective June 19, 2026, succeeding Trent Thrash who remains Senior Vice President.(view source)
|
|
$92.6M · -80.8% 1Y · Board D · HIGH activist risk
Daren Thayne has resigned from his position as Chief Technology Officer and Executive Vice President of Product at Domo, Inc., effective July 10, 2026, to take another executive role outside the company.(view source)
|
|
$23.0M · -55.7% 1Y · Board D · ELEVATED activist risk
Gil Issachar transitions from Chief Technology Officer to Head of AI and Neuroscience on June 18, 2026.(view source)
|
Energy— 6 companies
|
$2.9B · +3.5% 1Y · Board C · ELEVATED activist risk
Mark A. Pytosh stepped down from his role as President and CEO, and Dane J. Neumann was appointed as the new President and CEO, effective June 18, 2026. Richard Roberts was appointed as Interim CFO, also on June 18, 2026.(view source)
|
|
$21.1B · -23.4% 1Y · Board B · HIGH activist risk
On June 23, 2026, Gregory M. Larson announced his resignation as Vice President – Accounting & Controller of Expand Energy Corporation, and Marcel Teunissen assumed the role of interim principal accounting officer while remaining CFO.(view source)
|
|
$6.3B · +73.9% 1Y · Board B+ · LOW activist risk
Mohit Singh has been appointed Senior Vice President and Chief Financial Officer of Archrock, Inc., effective July 6, 2026, succeeding Douglas S. Aron, who will resign from his role on June 30, 2026.(view source)
|
|
$1.5B · +31.2% 1Y · Board C+ · ELEVATED activist risk
On June 16, 2026, Ben M. Palmer announced his retirement as Director, President, and CEO of RPC, Inc., effective either upon the appointment of a successor or by December 31, 2026, after which he will serve in an advisory role during the transition.(view source)
|
|
$135.6B · +23.5% 1Y · Board B- · ELEVATED activist risk
Kelly B. Rose will retire from her role as Senior Vice President, Legal, General Counsel and Corporate Secretary on September 1, 2026.(view source)
|
|
$416.2M · -2.2% 1Y · Board D · HIGH activist risk
Bartolomeo A. Frabotta has been appointed Chief Operating Officer of Clean Energy Fuels Corp. effective June 23, 2026.(view source)
|
Consumer Defensive— 8 companies
|
$43.5B · +1.9% 1Y · Board C · ELEVATED activist risk
|
|
$7.2B · -10.5% 1Y · Board C- · HIGH activist risk
On June 24, 2026, Philip Whitehead, the CEO of EMEA&APAC, is temporarily stepping away due to medical reasons, while Simon Kerry is appointed as the interim Managing Director of EMEA&APAC.(view source)
|
|
$1.0B · -80.6% 1Y · Board C+ · ELEVATED activist risk
Douglas J. Cornille is stepping down from the role of Chief Growth Officer effective June 24, 2026, and will depart the company on September 1, 2026.(view source)
|
|
$345.4B · +18.8% 1Y · Board B+ · LOW activist risk
Jennifer Mann is exiting her role as Executive Vice President and President of North America Operating Unit, while John Murphy is entering an interim role to oversee the same unit.(view source)
|
|
$6.5B · -26.9% 1Y · Board D · HIGH activist risk
Emanuel Chirico is exiting the Board of Directors, as he has decided not to stand for reelection.(view source)
|
|
$2.8B · -21.4% 1Y · Board C+ · HIGH activist risk
Scott Morris is retiring as President of Freshpet effective October 20, 2026, and Nicola Baty will assume the role of President on the same date.(view source)
|
|
$3.8B · -22.9% 1Y · Board B- · LOW activist risk
On June 22, 2026, Jack A. Henry resigned as a Director from the Board, and Dr. Chevy Humphrey was appointed as Chair of the Audit Committee, while Kevin Warren became Chair of the Compensation Committee.(view source)
|
|
$3.7B · -17.1% 1Y · Board B+ · LOW activist risk
On June 23, 2026, Haley R. Fisackerly and Michael J. Highfield were appointed as independent directors of Cal-Maine Foods, Inc., joining the Board of Directors.(view source)
|
Real Estate— 3 companies
|
$13.1B · -64.8% 1Y · Board D · HIGH activist risk
At CoStar Group’s Annual Meeting on June 23, 2026, several nominees were elected to the Board of Directors for terms until the 2027 Annual Meeting.(view source)
|
|
$794.1M · -24.1% 1Y · Board D · HIGH activist risk
On June 18, 2026, Andrew Wattula resigned from his role as Chief Operating Officer of Hudson Pacific Properties, Inc.(view source)
|
|
$1.3B · -3.4% 1Y · Board C · LOW activist risk
Kevin Miller has been appointed Executive Vice President, Chief Financial Officer and Treasurer, effective June 1, 2026.(view source)
|
Communication Services— 2 companies
|
$3.2B · +16.3% 1Y · Board C- · HIGH activist risk
Christopher Currier was appointed Chief Accounting Officer, and Michael H. Schwerdtman retired from the same position, both effective June 16, 2026.(view source)
|
|
$401.8M · -62.8% 1Y · Board C- · HIGH activist risk
James P. Chambers, Tarun Lal, Nathaniel J. Lipman, Charles H. Protell, Kevin M. Sheehan, and Allen R. Weiss were elected to Dave & Buster’s Board of Directors during the annual meeting of shareholders.(view source)
|
Utilities— 1 company
|
$2.8B · -9.5% 1Y · Board C- · ELEVATED activist risk
James J. Lorenz will retire as Vice President – Energy Operations on December 31, 2026, and John T. Robson will be appointed as his successor in that role effective January 1, 2027.(view source)
|
Activist risk and board ratings are derived from Boardroom Alpha’s proprietary scoring. Activist risk is forward-looking — a quantitative estimate of likelihood of activist engagement, not a current campaign. Board ratings reflect the average tenure-quality score of focal directors. TSR and S&P 500 spreads are annualized.